Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 33,104 | 61,446 | 85,612 | 62,957 |
| Marketable Securities | 73,691 | 60,912 | N/A | N/A |
| Receivables | 1,284 | 524 | 129 | 890 |
| TOTAL | $113,187 | $123,527 | $86,008 | $64,195 |
| Non-Current Assets | ||||
| PPE Net | 2,353 | 1,228 | 199 | 99 |
| Investments And Advances | 13,165 | 36,364 | 0 | 0 |
| Other Non-Current Assets | 38 | 70 | 9 | 9 |
| TOTAL | $15,556 | $37,662 | $208 | $108 |
| Total Assets | $128,743 | $161,189 | $86,216 | $64,303 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,052 | 3,685 | 2,097 | 3,255 |
| Accrued Expenses | 8,457 | 8,595 | 2,119 | 1,406 |
| Other current liabilities | 298 | 265 | 2 | 208 |
| TOTAL | $11,807 | $12,545 | $4,218 | $38,480 |
| Non-Current Liabilities | ||||
| Deferred Revenues | N/A | N/A | N/A | 29,611 |
| Other Non-Current Liabilities | 749 | 1,570 | 6,244 | 1,706 |
| TOTAL | $749 | $1,570 | $6,244 | $1,706 |
| Total Liabilities | $12,556 | $14,115 | $10,462 | $40,186 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 21,417 | 17,642 | N/A | N/A |
| Common Shares | 23 | 22 | 14 | 14 |
| Retained earnings | -62,151 | -10,349 | -20,572 | -71,493 |
| Other shareholders' equity | -158 | -180 | 19,149 | 19,149 |
| TOTAL | $116,187 | $147,074 | $75,754 | $24,117 |
| Total Liabilities And Equity | $128,743 | $161,189 | $86,216 | $64,303 |